Bloomage Biotechnology Corporation Limited — Investor Relations & Filings
About Bloomage Biotechnology Corporation Limited
Bloomage Biotechnology Corporation Limited is a global leader in the research, development, and production of hyaluronic acid and other bioactive substances. Utilizing advanced microbial fermentation and cross-linking technologies, the company provides high-quality raw materials for the pharmaceutical, cosmetic, and food sectors. Its product portfolio includes pharmaceutical-grade sodium hyaluronate, medical devices for ophthalmology and orthopedics, and aesthetic medicine solutions such as dermal fillers. Additionally, Bloomage develops and markets functional skin care brands and health foods. As the world's largest manufacturer of hyaluronic acid, the company maintains a vertically integrated industrial chain, focusing on biotechnology innovation to enhance human health and beauty. Its operations span global markets, serving diverse sectors with high-purity bioactive ingredients and finished consumer products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 华熙生物科技股份有限公司会计师事务所选聘制度（2025年5月修订） | 2025-05-19 | Chinese | |
| 华熙生物科技股份有限公司董事会秘书工作规则（2025年5月修订） | 2025-05-19 | Chinese | |
| 华熙生物科技股份有限公司独立董事工作制度（2025年5月修订） | 2025-05-19 | Chinese | |
| 华熙生物科技股份有限公司募集资金管理制度（2025年5月修订） | 2025-05-19 | Chinese | |
| 华熙生物科技股份有限公司董事、高级管理人员及核心技术人员所持本公司股份及其变动管理制度（2025年5月） | 2025-05-19 | Chinese | |
| 华熙生物科技股份有限公司章程（2025年5月修订） | 2025-05-19 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2025
15 filings
| |||||
| 39082552 | 华熙生物科技股份有限公司会计师事务所选聘制度（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082548 | 华熙生物科技股份有限公司董事会秘书工作规则（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082543 | 华熙生物科技股份有限公司独立董事工作制度（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082534 | 华熙生物科技股份有限公司募集资金管理制度（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082528 | 华熙生物科技股份有限公司董事、高级管理人员及核心技术人员所持本公司股份及其变动管理制度（2025年5月） | 2025-05-19 | Chinese | ||
| 39082518 | 华熙生物科技股份有限公司章程（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082511 | 独立董事提名人声明与承诺（姚洋） | 2025-05-19 | Chinese | ||
| 39082507 | 华熙生物科技股份有限公司风险管理委员会议事规则（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082504 | 独立董事候选人声明与承诺（徐文鸣） | 2025-05-19 | Chinese | ||
| 39082498 | 关于董事会换届选举的公告 | 2025-05-19 | Chinese | ||
| 39082493 | 华熙生物科技股份有限公司对外投资管理制度（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082489 | 华熙生物科技股份有限公司董事会议事规则（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082484 | 华熙生物科技股份有限公司信息披露管理制度（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082475 | 华熙生物科技股份有限公司内幕信息知情人登记管理制度（2025年5月修订） | 2025-05-19 | Chinese | ||
| 39082471 | 华熙生物科技股份有限公司战略委员会工作细则（2025年5月修订） | 2025-05-19 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Bloomage Biotechnology Corporation Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/58370/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=58370 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=58370 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=58370 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 58370}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Bloomage Biotechnology Corporation Limited (id: 58370)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.